本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

546.89
+17.053.22%
盘后545.24-1.6500-0.30%19:22 EDT
成交量:34.50万
成交额:1.86亿
市值:125.46亿
市盈率:-42.56
高:547.98
开:531.19
低:522.49
收:529.84
52周最高:615.00
52周最低:265.00
股本:2,294.00万
流通股本:1,100.01万
量比:0.55
换手率:3.14%
股息:- -
股息率:- -
每股收益(TTM):-12.8501
每股收益(LYR):-12.8501
净资产收益率:-42.49%
总资产收益率:-16.30%
市净率:20.82
市盈率(LYR):-42.56

数据加载中...

2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]